Urology Practice Management December 2014

Page 1

FOR UROLOGISTS, PRACTICE MANAGERS, FINANCIAL COUNSELORS, AND REIMBURSEMENT SPECIALISTS™

DECEMBER 2014

www.UroPracticeManagement.com

New Practice Guideline for Systemic Therapy in Men with Metastatic Prostate Cancer By Rosemary Frei, MSc

VOLUME 3 • NUMBER 6

Enzalutamide Improves Survival After ADT in Patients with CRPC By Robert Osborne

Orlando, FL—Treatment with enzalutamide (Xtandi) after progression with androgen-deprivation therapy (ADT) led to a significant improvement in survival for men with metastatic castration-resistant prostate cancer (mCRPC), according to a new randomized trial reported at the 2014

American Urological Association annual meeting. Patients randomized to placebo had a median radiographic progression-free survival (PFS; primary end point) of 3.9 months, whereas the median had not been reached in the enzalutamide Continued on page 20

Where Did My Data Go? By Teri U. Guidi, MBA, FAAMA, President and CEO Oncology Management Consulting Group

A

Ethan Basch, MD, MSc

new guideline for systemic therapy in men with metastatic castration-resistant prostate cancer (mCRPC) is based on a literature review of recent publications and outlines the survival and quality-of-life benefits/toxicity effects of each recommendation (Basch Continued on page 11

T

here is no denying the trend of medical oncology practices being acquired by hospitals, whether through professional service agreements, employer–employee agreements, or something in between. The 2013 Community Oncology Practice Impact Report1—published by the Community

Oncology Alliance— shows that in the past 6 years, 469 (35%) of 1338 responding practices have been acquired, and the rate of acquisition has increased 20% in the 15 months since the 2012 report. Across the country, educational sesContinued on page 14

ES r: C e UR blower SO istle loy E R Wh mp 6

r E 2 AN le o s an ?… M ta t’ Do HU attle Wha to © 2014 Engage Healthcare Communications, LLC

T


Millions discover their favorite reads on issuu every month.

Give your content the digital home it deserves. Get it to any device in seconds.